Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations

被引:0
|
作者
Kawasaki, T [1 ]
Tomita, Y [1 ]
Bilim, V [1 ]
Takeda, M [1 ]
Takahashi, K [1 ]
Kumanishi, T [1 ]
机构
[1] NIIGATA UNIV,BRAIN RES INST,DEPT MOL NEUROPATHOL,NIIGATA 951,JAPAN
关键词
D O I
10.1002/(SICI)1097-0215(19961115)68:4<501::AID-IJC16>3.0.CO;2-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The P53-inducible cyclin-dependent kinase inhibitor, p21/WAF1/CIP1 (P21), plays a pivotal role in the G(1) arrest or apoptosis of cells exposed to genotoxic stimuli. To determine whether p21 is a putative tumor-suppressor gene, p21 status was investigated in 4 human bladder-cancer cell lines of known p53 status. A p21-gene mutation, one base-pair insertion at codon 20 resulting in a chain-termination change at codon 35, was observed in one cell line, HT1376, suggesting structural or functional alteration of the p21 protein. When exposed to DNA-damaging agents, cisplatin or mitomycin C, apoptosis was induced in RT4 with the wild-type (wt) p53/wt p21, whereas T24 with the p53 non-sense mutation/wt p21 was resistant. Of the other 2 cell lines with the p53 mis-sense mutation, apoptosis was induced in SCaBER with the wt p21, but HT1376 with the p21 frame-shift mutation was fairly resistant. These findings suggest that not only p53 alteration, but also P21 alteration, is important to prevent apoptosis induced by DNA-damaging agents. When exposed to these agents, p53 and p21 expression was increased in RT4, and not induced in T24. p53 was not induced, but PZ I expression was increased in SCaBER, whereas p53 expression was increased but PZ I expression was absent in HT1376. Thus, p21 expression itself may have an important role in the induction of apoptosis by DNA-damaging agents. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 50 条
  • [41] P21 (WAF1/CIP1) can inhibit cardiac myocyte apoptosis
    Wang, J
    Cakulev, IT
    Abdellatif, M
    Schneider, MD
    CIRCULATION, 2000, 102 (18) : 168 - 169
  • [42] Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients
    Bau, Da-Tian
    Tsai, Ming-Hsui
    Lo, Yen-Li
    Hsu, Chin-Moo
    Tsai, Yuhsin
    Lee, Cheng-Chun
    Tsai, Fuu-Jen
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1559 - 1564
  • [43] The pattern of p53 and p21(WAF1/CIP1) immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status
    Mansukhani, MM
    Osborne, BM
    Zhong, JY
    Matsushima, AY
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1997, 6 (04) : 222 - 228
  • [44] The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis
    Gartel, AL
    LEUKEMIA RESEARCH, 2005, 29 (11) : 1237 - 1238
  • [45] Expression of p21(Waf1/Cip1) in hepatoma cell lines during differentiation.
    Yamamoto, H
    Hashimoto, T
    Ueki, T
    Okamoto, E
    Furuyama, J
    Fujimoto, J
    HEPATOLOGY, 1996, 24 (04) : 1892 - 1892
  • [46] p21/waf1/cip1 In gastric cancer:: Associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status
    Baldus, SE
    Schneider, PM
    Mönig, SP
    Zirbes, TK
    Fromm, S
    Meyer, W
    Glossmann, J
    Schüler, S
    Thiele, J
    Hölscher, AH
    Dienes, HP
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (09) : 975 - 980
  • [47] Architectural accommodation in the complex of four p53 DNA binding domain peptides with the p21/waf1/cip1 DNA response element
    Nagaich, AK
    Zhurkin, VB
    Sakamoto, H
    Gorin, AA
    Clore, GM
    Gronenborn, AM
    Appella, E
    Harrington, RE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) : 14830 - 14841
  • [48] A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers
    Shiraishi, T
    Watanabe, M
    Muneyuki, T
    Nakayama, T
    Morita, J
    Ito, H
    Kotake, T
    Yatani, R
    UROLOGIA INTERNATIONALIS, 1998, 61 (02) : 90 - 94
  • [49] Expression of the p53 induced tumor suppressor p21(waf1/cip1) in ovarian carcinomas: Correlation with p53 and Ki-67 immunohistochemistry
    Werness, BA
    Jobe, JS
    DiCioccio, RA
    Piver, MS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1997, 16 (02) : 149 - 155
  • [50] p21(Waf1/Cip1/Sdi1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis
    Kuwano, K
    Kunitake, R
    Kawasaki, M
    Nomoto, Y
    Hagimoto, N
    Nakanishi, Y
    Hara, N
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (02) : 477 - 483